Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Errors of red cell concentrates recipients: method of analysis using the adverse events notified to the hemovigilance network in 2009].

Falzone E, Auroy Y, Hoffmann C, Sandid I, Carlier M, Benhamou D, Andreu G, Lienhart A; groupe de travail « Analyse des causes racines » de la Commission nationale d’hémovigilance.

Transfus Clin Biol. 2012 Dec;19(6):338-44. doi: 10.1016/j.tracli.2012.06.004. Epub 2012 Oct 25. French.

PMID:
23103422
2.

[Advancement in the preparation of red cell concentrates and platelet concentrates].

Inaba S.

Masui. 2011 Jan;60(1):23-30. Review. Japanese.

PMID:
21348247
3.

Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.

Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Hervé P.

Transfusion. 2002 Oct;42(10):1356-64.

PMID:
12423521
4.
5.

The Quebec hemovigilance system: description and results from the first two years.

Robillard P, Nawej KI, Jochem K.

Transfus Apher Sci. 2004 Oct;31(2):111-22.

PMID:
15501415
6.

Failure of bedside ABO testing is still the most common cause of incorrect blood transfusion in the Barcode era.

Ahrens N, Pruss A, Kiesewetter H, Salama A.

Transfus Apher Sci. 2005 Aug;33(1):25-9.

PMID:
15964241
7.

Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.

Ozier Y, Muller JY, Mertes PM, Renaudier P, Aguilon P, Canivet N, Fabrigli P, Rebibo D, Tazerout M, Trophilme C, Willaert B, Caldani C.

Transfusion. 2011 Oct;51(10):2102-10. doi: 10.1111/j.1537-2995.2011.03073.x. Epub 2011 Mar 7.

PMID:
21382042
8.

Online reporting system for transfusion-related adverse events to enhance recipient haemovigilance in Japan: a pilot study.

Odaka C, Kato H, Otsubo H, Takamoto S, Okada Y, Taneichi M, Okuma K, Sagawa K, Hoshi Y, Tasaki T, Fujii Y, Yonemura Y, Iwao N, Tanaka A, Okazaki H, Momose SY, Kitazawa J, Mori H, Matsushita A, Nomura H, Yasoshima H, Ohkusa Y, Yamaguchi K, Hamaguchi I.

Transfus Apher Sci. 2013 Feb;48(1):95-102. doi: 10.1016/j.transci.2012.07.008. Epub 2012 Sep 3.

PMID:
22954634
9.

Experience with the medical event reporting system for transfusion medicine (MERS-TM) at three hospitals.

Callum JL, Merkley LL, Coovadia AS, Lima AP, Kaplan HS.

Transfus Apher Sci. 2004 Oct;31(2):133-43.

PMID:
15501417
10.

Root-cause analysis of a potentially sentinel transfusion event: lessons for improvement of patient safety.

Adibi H, Khalesi N, Ravaghi H, Jafari M, Jeddian AR.

Acta Med Iran. 2012;50(9):624-31.

11.

Enhanced detection of blood bank sample collection errors with a centralized patient database.

MacIvor D, Triulzi DJ, Yazer MH.

Transfusion. 2009 Jan;49(1):40-3. doi: 10.1111/j.1537-2995.2008.01923.x. Epub 2008 Sep 16.

PMID:
18798804
12.

Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates.

Flesland O, Ip LS, Storlien AS, Spurkland A, Larsen J, Solheim BG.

Transfus Apher Sci. 2004 Dec;31(3):173-80.

PMID:
15556463
13.

New technology for transfusion safety.

Dzik WH.

Br J Haematol. 2007 Jan;136(2):181-90. Epub 2006 Nov 8. Review.

PMID:
17092308
14.

The role and impact of the transfusion medicine consultation service in the management of patients in the hematopoietic transplant service: A retrospective analysis.

Narvios A, Rodriguez-Jackson L, Reddy V, Lichtiger B.

Transfus Clin Biol. 2009 Sep;16(4):383-7. doi: 10.1016/j.tracli.2009.06.003. Epub 2009 Aug 7.

PMID:
19665413
15.

Hemovigilance: clinical tolerance of solvent-detergent treated plasma.

Baudoux E, Margraff U, Coenen A, Jacobs X, Strivay M, Lungu C, Sondag-Thull D.

Vox Sang. 1998;74 Suppl 1:237-9.

PMID:
9789535
16.

[Pathogen inactivation in labile blood products: transfusion safety and economic impact].

Cazenave JP.

Bull Acad Natl Med. 2006 Jan;190(1):169-85; discussion 186-8. Review. French.

PMID:
16878453
17.

Network computer-assisted transfusion-management system for accurate blood component-recipient identification at the bedside.

Miyata S, Kawai T, Yamamoto S, Takada M, Iwatani Y, Uchida O, Imanaka H, Sase K, Yagihara T, Kuro M.

Transfusion. 2004 Mar;44(3):364-72.

PMID:
14996193
18.

Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.

Moncharmont P, Barday G, Py JY, Meyer F; National Haemovigilance Network of the French Blood Establishment.

Blood Transfus. 2017 May;15(3):254-258. doi: 10.2450/2016.0328-15. Epub 2017 Jul 5.

19.

Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up.

Walther-Wenke G, Schrezenmeier H, Deitenbeck R, Geis G, Burkhart J, Höchsmann B, Sireis W, Schmidt M, Seifried E, Gebauer W, Liebscher UM, Weinauer F, Müller TH.

Ann Hematol. 2010 Jan;89(1):83-91. doi: 10.1007/s00277-009-0762-2. Epub 2009 May 30.

PMID:
19484239
20.

Supplemental Content

Support Center